Does Ozempic Affect Your Period? Insights and What You Need to Know

Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide and other GLP-1 medications are highly effective for weight management, but patients often wonder about less-discussed side effects—including changes to the menstrual cycle. Research shows that rapid weight loss itself, combined with hormonal shifts from GLP-1 therapy, can alter period timing, flow, and frequency. Here's what you need to know.

How Semaglutide Affects Hormonal Balance and Menstruation

GLP-1 receptor agonists work by mimicking glucagon-like peptide-1, a hormone that regulates appetite and blood sugar. This mechanism influences the hypothalamic-pituitary-gonadal axis, which controls reproductive hormones like estrogen and progesterone. When your body enters a caloric deficit—especially a rapid one—the brain may temporarily reduce production of gonadotropin-releasing hormone (GnRH), which signals your ovaries to produce sex hormones. This downstream effect can delay or lighten menstrual periods.

Weight loss itself is a primary driver of menstrual changes on GLP-1 therapy. The body stores estrogen in fat tissue, so losing 5–10% of body weight can measurably shift circulating estrogen levels. Additionally, improved insulin sensitivity from semaglutide may normalize hormonal patterns in people with insulin resistance or polycystic ovary syndrome (PCOS), sometimes making cycles more regular over time. Most menstrual adjustments stabilize within 3–6 months as your body adapts to its new weight set point.

Common Menstrual Changes While Taking GLP-1 Medications

Patients on semaglutide report several patterns: delayed or skipped periods (amenorrhea), lighter bleeding, shorter cycles, or longer cycles. Amenorrhea lasting longer than three months is less common but warrants a conversation with your healthcare provider. Interestingly, some patients—especially those with PCOS—experience *improved* cycle regularity because GLP-1 therapy reduces insulin levels and supports metabolic health. The variability depends on how quickly you lose weight, your baseline hormone levels, and individual genetics.

Breakthrough bleeding or spotting between periods can also occur as your body adjusts to lower estrogen levels. This is typically benign and resolves as you stabilize at your new weight. Tracking your cycle on a calendar or period-tracking app helps distinguish normal adaptation from a pattern requiring medical evaluation. If amenorrhea extends beyond three months, irregular bleeding worsens, or you experience severe cramping, notify your prescribing clinician immediately.

Clinical Evidence and Trial Data on GLP-1 and Menstrual Health

Most large semaglutide trials (STEP 1–4) did not specifically measure menstrual changes as a primary endpoint, but real-world data from clinical practices shows the phenomenon is well-documented. A 2023 analysis of GLP-1 users found that approximately 15–25% of reproductive-age women experienced menstrual irregularity during the first three months of therapy, with the majority resolving by month six. Women who lost more than 15% body weight showed higher rates of temporary amenorrhea, which normalized as weight stabilized.

The mechanism aligns with decades of research on weight loss and reproductive health: a 2019 study in *Obesity* demonstrated that even modest weight loss (5–10%) can shift estrogen metabolism and cycle regularity. On GLP-1 therapy, this effect is often more pronounced because weight loss occurs faster than with diet alone. Importantly, these changes are almost always reversible, and fertility is not permanently affected once treatment ends and weight stabilizes.

Managing Menstrual Changes on PlexusDx Semaglutide Treatment

If you experience menstrual irregularity on semaglutide, the first step is patience and tracking. Keep a detailed log of cycle dates, flow intensity, and any other symptoms for at least two cycles. Most shifts resolve naturally within 3–6 months as your metabolism adapts. Maintain adequate nutrition—undereating while on GLP-1 can exacerbate hormonal disruption—and stay hydrated, as dehydration can worsen cycle irregularity. If you're interested in genetic insights about how your body processes metabolic and reproductive hormones, PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment), which maps 14 pathways and 150+ genetic insights including variants affecting the FTO and MC4R genes linked to weight regulation and hormone sensitivity.

Communicate openly with your PlexusDx clinician about menstrual changes. If amenorrhea lasts longer than three months, if bleeding becomes unusually heavy or painful, or if you're concerned about fertility, your provider may recommend a brief pause in dose escalation or evaluation by a gynecologist. Hormonal contraceptives can stabilize your cycle if desired, and these are compatible with semaglutide therapy. Never stop treatment abruptly without medical guidance—instead, discuss your concerns and work toward a plan that supports both your weight loss and reproductive health.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is it normal to skip a period while taking semaglutide?

Yes, skipped or delayed periods are relatively common in the first 3–6 months of GLP-1 therapy, especially if you're losing weight rapidly. This occurs because weight loss lowers estrogen levels. However, if amenorrhea continues beyond three months, consult your PlexusDx clinician or a gynecologist to rule out other causes.

Will semaglutide affect my ability to get pregnant?

GLP-1 medications do not permanently impair fertility. Temporary menstrual irregularity does not mean you cannot conceive. However, if you plan to become pregnant, discuss timing with your provider, as rapid weight loss may not be ideal during pregnancy. Most fertility returns to baseline after treatment ends and weight stabilizes.

How much does PlexusDx Semaglutide Injection cost?

PlexusDx Compounded Semaglutide Injection starts at $149 per month—your dose may need to go up, but your price won't. All medications come from licensed 503A compounding pharmacies, and treatment is available in all 50 states without insurance or membership fees. HSA and FSA accounts are eligible.

What if my period becomes heavier or more painful on semaglutide?

Increased menstrual pain or heavy bleeding is less common but should be evaluated by your healthcare provider. This may indicate a separate gynecological issue unrelated to semaglutide, or rarely, a sign that your dose needs adjustment. Do not self-diagnose—seek professional guidance promptly.

Can the Precision Peptide Genetic Test predict my risk of menstrual changes on GLP-1?

The PlexusDx Precision Peptide Genetic Test ($99 add-on) analyzes genetic variants in the FTO and MC4R genes, among 49 peptides across 14 metabolic pathways. While it doesn't directly predict menstrual side effects, it reveals your genetic predisposition to weight regulation patterns and insulin sensitivity, which influence how your body responds to GLP-1 therapy and weight loss—factors that drive menstrual changes.

Related Reading

• Genetic Testing 101 What You Need To Know Before Getting Tested
• Does Foxo3 Affect How You Age
• What Genetic Factors Determine How Much Sleep You Need Each Night
• Does My Dna Affect How Much Sleep I Need For Mental Clarity

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.